ArticleFrontiers in medicine2025
Machine learning-enabled prediction of bone metastasis in esophageal cancer.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development and validation of prediction model for intrapulmonary metastasis in lung adenocarcinoma based on machine learning.Journal of thoracic disease · 2026Article
- Machine learning applications in the detection and treatment of esophageal cancer.Discover oncology · 2026Review
- Machine learning to predict distant metastasis risk and prognostic analysis in T1-2 esophageal cancer: a study based on the SEER database.Journal of thoracic disease · 2026Article
- Deep Learning-Based 30-Day Mortality Prediction in Critically Ill Bone and Bone Marrow Metastasis Patients: A Multicenter Retrospective Cohort Study.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Bone metastasis (BM) is a common manifestation of distant spread in patients with esophageal cancer. This study aimed to develop a machine learning algorithm to predict the risk of bone metastasis in esophageal cancer patients, thereby supporting clinical decision-making support. Methods: Clinical and pathological data of esophageal cancer patients were obtained from the SEER database of the U.S. National Institutes of Health from 2010 to 2020. Six machine learning models were constructed: Support Vector Machine, Logistic Regression, Extreme Gradient Boosting, Neural Network, Random Forest, and k-Nearest Neighbors. Models performance was evaluated using accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve. The optimal model was further used to interpret the associations between clinicopathological features and bone metastasis. Results: A total of 9,744 patients were included, with 532 (5.47%) had bone metastasis and 9,212 (94.53%) without. Multivariate logistic regression analysis identified age, T stage, N stage, and histological type as independent risk factors for bone metastasis. The XGBoost model demonstrated the best performance, achieving an accuracy of 0.80, a recall of 0.99, a precision of 0.72, an F1-score of 0.8300, and AUC of 0.92. Conclusion: The XGBoost model showed excellent predictive performance for bone metastasis in esophageal cancer patients, providing valuable insights for guiding clinical treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.